ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,838, issued on Jan. 20, was assigned to Nevada Research & Innovation Corp. (Reno, Nev.) and The Board of Trustees of the University of Illinois (Urbana, Ill.).

"Cyclic dominant negative competence stimulating peptide analogs and methods of treating Streptococcus pneumoniae infections" was invented by Yftah Tal-Gan (Reno, Nev.), Gee W. Lau (Urbana, Ill.) and Yifang Yang (Reno, Nev.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions, methods of treatment and kits for treating Streptococcus Pneumoniae infections. In some examples, compositions including cyclic dominant negative competence stimulating peptide analogs are di...